Ackermans & Van Haaren NV (EBR:ACKB)
193.70
-2.40 (-1.22%)
Mar 11, 2025, 1:28 PM CET
Ackermans & Van Haaren NV Revenue
In the year 2024, Ackermans & Van Haaren NV had annual revenue of 6.04B EUR with 15.74% growth. Ackermans & Van Haaren NV had revenue of 3.16B in the half year ending December 31, 2024, with 39.18% growth.
Revenue
6.04B
Revenue Growth
+15.74%
P/S Ratio
1.06
Revenue / Employee
247.84K
Employees
24,384
Market Cap
6.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.04B | 821.78M | 15.74% |
Dec 31, 2023 | 5.22B | 820.13M | 18.63% |
Dec 31, 2022 | 4.40B | 104.05M | 2.42% |
Dec 31, 2021 | 4.30B | 387.12M | 9.90% |
Dec 31, 2020 | 3.91B | -360.15M | -8.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DEME Group NV | 4.10B |
Umicore | 14.85B |
Cenergy Holdings | 1.80B |
NV Bekaert | 3.96B |
Viohalco | 6.34B |
Recticel | 610.20M |
Floridienne | 598.67M |
Jensen-Group NV | 453.17M |
Ackermans & Van Haaren NV News
- 5 days ago - Full Year 2024 Ackermans & Van Haaren NV Earnings P Transcript - GuruFocus
- 11 days ago - Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros. - GlobeNewsWire
- 3 months ago - Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros - GlobeNewsWire
- 3 months ago - Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co - GlobeNewsWire
- 5 months ago - Ackermans & van Haaren invests an additional 5 million euros in Biotalys - GlobeNewsWire
- 6 months ago - Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%) - GlobeNewsWire
- 8 months ago - Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company - GlobeNewsWire
- 10 months ago - Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a large majority - GlobeNewsWire